Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
about
Escherichia coli redox mutants as microbial cell factories for the synthesis of reduced biochemicals.Multiple phenotypic changes associated with large-scale horizontal gene transfer.Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.Host cell protein analysis in therapeutic protein bioprocessing - methods and applications.Production and purification of plasmid DNA vaccines: is there scope for further innovation?Maximizing the stability of metabolic engineering-derived whole-cell biocatalysts.A reduced genome decreases the host carrying capacity for foreign DNA.Interactions between horizontally acquired genes create a fitness cost in Pseudomonas aeruginosa.Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.Et tu, Brute? Not Even Intracellular Mutualistic Symbionts Escape Horizontal Gene Transfer.Validation and scale-up of plasmid DNA purification by phenyl-boronic acid chromatography.De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.In situNIR spectroscopy monitoring of plasmid production processes: effect of producing strain, medium composition and the cultivation strategy
P2860
Q27004040-EA2E08CC-4D5A-43A8-8B57-635BA27BC8DBQ35210627-A390521A-B2CD-4ED6-A2FB-DC9096EDDE33Q35826665-285EFE95-D4A0-41D4-B025-FE4BCA38A89AQ38079490-A8262E3C-DD8A-47C8-B3F1-21BE977C0C66Q38084258-04634C45-D03F-41D9-9A83-AED2D91E8B49Q38259502-BF28ED48-E289-4AF7-9527-B2660F10D7F4Q39441761-BD117D02-3F13-47C1-A1CD-1851C4F79B17Q39620417-874012BF-73E0-48F8-A8EE-8952B5CE448AQ39977166-A07EC094-48BB-403F-813A-36830606C5B9Q41699306-BD31CB62-BB61-4A22-80F3-04725D03CCD5Q42909565-A963E3ED-DC6C-414D-A7F1-92663CF61F3CQ54322953-1CF1F3D6-4B47-41A3-9884-69D2B0F4FD3EQ54330466-7859D924-7B67-4DDC-9005-E163FA564C91Q58853173-7342B567-21C6-4CF6-ABF9-54B0C8FE8783
P2860
Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rational engineering of Escher ...... opharmaceutical manufacturing.
@en
Rational engineering of Escher ...... opharmaceutical manufacturing.
@nl
type
label
Rational engineering of Escher ...... opharmaceutical manufacturing.
@en
Rational engineering of Escher ...... opharmaceutical manufacturing.
@nl
prefLabel
Rational engineering of Escher ...... opharmaceutical manufacturing.
@en
Rational engineering of Escher ...... opharmaceutical manufacturing.
@nl
P2093
P2860
P356
P1476
Rational engineering of Escher ...... opharmaceutical manufacturing.
@en
P2093
Diana M Bower
Duarte M F Prazeres
Geisa A L Gonçalves
Kristala L J Prather
P2860
P304
P356
10.1002/BIOT.201100062
P577
2011-09-13T00:00:00Z